| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035432840 |
| P356 | DOI | 10.1186/1741-7015-11-8 |
| P932 | PMC publication ID | 3570360 |
| P698 | PubMed publication ID | 23302153 |
| P5875 | ResearchGate publication ID | 234097879 |
| P2093 | author name string | C W le Roux | |
| T Olbers | |||
| K J Neff | |||
| P2860 | cites work | Factors Associated with Operative Outcomes in Laparoscopic Gastric Bypass | Q46337897 |
| Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial | Q46351079 | ||
| Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. | Q46660176 | ||
| The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery | Q46724489 | ||
| Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia | Q46729194 | ||
| Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial | Q46881496 | ||
| Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal | Q46982079 | ||
| Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery | Q47190314 | ||
| Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. | Q47239778 | ||
| Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass | Q47263805 | ||
| Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. | Q47312548 | ||
| Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss | Q47343464 | ||
| Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters | Q47356520 | ||
| Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial | Q47357101 | ||
| Negotiating control: patients' experiences of unsuccessful weight-loss surgery | Q47361908 | ||
| The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass | Q47363066 | ||
| ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients. | Q47368574 | ||
| Surgically induced weight loss, including reduction in waist circumference, is associated with improved pulmonary function in obese patients | Q47370658 | ||
| Smaller staple height for circular stapled gastrojejunostomy in laparoscopic gastric bypass: early results in 1,074 morbidly obese patients | Q47405223 | ||
| Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. | Q47418018 | ||
| Biliopancreatic diversion with a duodenal switch | Q47790710 | ||
| Is mandatory screening for obstructive sleep apnea with polysomnography in all severely obese patients indicated? | Q48300324 | ||
| Preoperative cardiac and pulmonary assessment in bariatric surgery. | Q48445998 | ||
| Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial | Q48475675 | ||
| The impact of renal function on outcomes of bariatric surgery | Q48562846 | ||
| Complications after sleeve gastrectomy for morbid obesity | Q50058719 | ||
| Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study | Q50708815 | ||
| The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus | Q50855237 | ||
| Sex hormone changes in morbidly obese patients after vertical banded gastroplasty | Q50904109 | ||
| Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up | Q51035502 | ||
| Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding. | Q51361660 | ||
| A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. | Q51378838 | ||
| Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. | Q51505083 | ||
| Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. | Q51717067 | ||
| A prospective study of body dissatisfaction and concerns in extremely obese gastric bypass patients: 6- and 12-month postoperative outcomes. | Q51770711 | ||
| Urinary and fecal incontinence after bariatric surgery. | Q51774663 | ||
| Impact of body mass index values on sperm quantity and quality. | Q51828783 | ||
| Evaluation of health status and quality of life after bariatric surgery: comparison of standard Roux-en-Y gastric bypass, vertical banded gastroplasty and laparoscopic adjustable silicone gastric banding. | Q53515815 | ||
| Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. | Q54656315 | ||
| Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial | Q58418687 | ||
| Musculoskeletal pain in the obese: a comparison with a general population and long-term changes after conventional and surgical obesity treatment | Q58418708 | ||
| Bilio-pancreatic bypass. Proposal and preliminary experimental study of a new type of operation for the functional surgical treatment of obesity | Q67827760 | ||
| Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study | Q78015407 | ||
| Does obesity surgery improve psychosocial functioning? A systematic review | Q79198838 | ||
| Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity | Q81110233 | ||
| A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways | Q81888136 | ||
| Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2 | Q82033141 | ||
| Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity | Q82457837 | ||
| Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity | Q82663391 | ||
| C-peptide predicts the remission of type 2 diabetes after bariatric surgery | Q82798859 | ||
| Gastrojejunal stricture after gastric bypass and efficacy of endoscopic intervention | Q82810911 | ||
| Comparison of staple-line leakage and hemorrhage in patients undergoing laparoscopic sleeve gastrectomy with or without Seamguard | Q83315246 | ||
| Effect of bariatric surgery on airway response and lung function in obese subjects with asthma | Q83426403 | ||
| Small bowel obstruction after antecolic and antegastric laparoscopic Roux-en-Y gastric bypass: could the incidence be reduced? | Q84075359 | ||
| Late marginal ulcers after gastric bypass for morbid obesity. Clinical and endoscopic findings and response to treatment | Q84497939 | ||
| Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2 | Q84699406 | ||
| Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score | Q84957056 | ||
| Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects | Q22250885 | ||
| Bariatric surgery for non-alcoholic steatohepatitis in obese patients | Q24240455 | ||
| Perioperative safety in the longitudinal assessment of bariatric surgery | Q24594848 | ||
| The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control | Q24629879 | ||
| Current endoscopic techniques in the treatment of obesity | Q26851456 | ||
| Long-term mortality after gastric bypass surgery | Q28241874 | ||
| NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel | Q28248503 | ||
| Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
| Bariatric surgery: a systematic review and meta-analysis | Q30769299 | ||
| Clinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US states. | Q33692832 | ||
| Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women | Q33737502 | ||
| Predictive factors of mortality in bariatric surgery: data from the Nationwide Inpatient Sample | Q33975824 | ||
| Systematic review of medium-term weight loss after bariatric operations | Q33998428 | ||
| Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. | Q34003940 | ||
| Metabolic/bariatric surgery Worldwide 2008. | Q34020011 | ||
| Expectations, validity, and reality in gene expression profiling | Q34020695 | ||
| Bariatric surgery and long-term cardiovascular events. | Q34030064 | ||
| Gastroesophageal reflux disease and severe obesity: Fundoplication or bariatric surgery? | Q34063689 | ||
| Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. | Q34079999 | ||
| Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention | Q34178727 | ||
| Bariatric surgery versus conventional medical therapy for type 2 diabetes | Q34263754 | ||
| Weight loss and early and late complications--the international experience | Q34530429 | ||
| Changes in quality of life and body image after gastric bypass surgery | Q34543644 | ||
| Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma | Q34554095 | ||
| Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up | Q34583219 | ||
| Pathophysiology, diagnosis and management of postoperative dumping syndrome | Q34611418 | ||
| Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures | Q34839947 | ||
| The liver in obesity and type 2 diabetes mellitus | Q35040091 | ||
| Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction | Q35140899 | ||
| The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery | Q35597958 | ||
| Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass | Q35635916 | ||
| Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery. | Q35645856 | ||
| Prospective changes in body image dissatisfaction among adolescent bariatric patients: the importance of body size estimation | Q35899176 | ||
| Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery | Q36001493 | ||
| Follow-up of nutritional and metabolic problems after bariatric surgery | Q36022807 | ||
| Bariatric surgery versus intensive medical therapy in obese patients with diabetes | Q36025669 | ||
| Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2) | Q36031995 | ||
| Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient | Q36084476 | ||
| Obstructive symptoms associated with the 9.75-cm Lap-Band in the first 24 hours using the pars flaccida approach | Q36096365 | ||
| Effect of vertical sleeve gastrectomy in melanocortin receptor 4-deficient rats. | Q36114849 | ||
| Roux-en-Y gastric bypass surgery for morbid obesity: evaluation of postoperative extraluminal leaks with upper gastrointestinal series | Q36351004 | ||
| Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. | Q36477817 | ||
| Two-year trends in psychosocial functioning after adolescent Roux-en-Y gastric bypass | Q36483420 | ||
| Complications of antiobesity surgery | Q36752656 | ||
| Psychosocial and behavioral status of patients undergoing bariatric surgery: what to expect before and after surgery | Q36825257 | ||
| Laparoscopic gastric band complications | Q36825265 | ||
| Sleeve gastrectomy as a bariatric procedure | Q37006770 | ||
| Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study | Q37112113 | ||
| Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding | Q37172260 | ||
| Reducing band slippage in laparoscopic adjustable gastric banding: the mesh plication pars flaccida technique. | Q37256532 | ||
| Lessons from extreme human obesity: monogenic disorders | Q37262319 | ||
| A study on the economic impact of bariatric surgery. | Q37263227 | ||
| Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. | Q37311858 | ||
| Effects of bariatric surgery on cardiovascular function | Q37322903 | ||
| Pregnancy and fertility following bariatric surgery: a systematic review | Q37328878 | ||
| Standardization of the fully stapled laparoscopic Roux-en-Y gastric bypass for obesity reduces early immediate postoperative morbidity and mortality: a single center study on 2606 patients. | Q37387778 | ||
| Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis | Q37409707 | ||
| Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis | Q37503873 | ||
| Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction | Q37597592 | ||
| Duodenal switch gastric bypass surgery for morbid obesity: imaging of postsurgical anatomy and postoperative gastrointestinal complications | Q37637534 | ||
| Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. | Q37640916 | ||
| Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies | Q37691676 | ||
| Impact of surgeon experience and buttress material on postoperative complications after laparoscopic sleeve gastrectomy | Q37762993 | ||
| Long-term results of laparoscopic sleeve gastrectomy for obesity | Q37771841 | ||
| Effects of obesity and subsequent weight reduction on left ventricular function | Q37816822 | ||
| Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. | Q37862878 | ||
| Metabolic surgery and cancer: protective effects of bariatric procedures | Q37867582 | ||
| Obesity and bariatric surgery: a systematic review of associations with defecatory dysfunction | Q37874702 | ||
| Preoperative predictors of weight loss following bariatric surgery: systematic review | Q37915396 | ||
| Surgical approaches to the treatment of obesity: bariatric surgery | Q37920224 | ||
| Management of late postoperative complications of bariatric surgery | Q37925691 | ||
| Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review | Q37967534 | ||
| Pregnancy and foetal outcome after bariatric surgery: a review of recent studies. | Q37984459 | ||
| Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials | Q37992337 | ||
| Health care use during 20 years following bariatric surgery | Q38463944 | ||
| Temporal trends in BMI among adults with diabetes | Q38492274 | ||
| Laparoscopic biliopancreatic diversion/duodenal switch or laparoscopic Roux-en-Y gastric bypass for super-obesity-weight loss versus side effects. | Q39282435 | ||
| Health and economic burden of the projected obesity trends in the USA and the UK. | Q39713652 | ||
| Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study | Q40234335 | ||
| Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates | Q42653582 | ||
| Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up | Q42669177 | ||
| Obstructive sleep apnoea and perioperative complications in bariatric patients | Q42679126 | ||
| Obesity costs UK economy 2bn pounds sterling a year | Q42733492 | ||
| In pursuit of "humanitarian science". | Q43030151 | ||
| A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery | Q43254450 | ||
| Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial | Q43474000 | ||
| Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass. | Q43510657 | ||
| Midlife body mass index and hospitalization and mortality in older age. | Q44676822 | ||
| Anxiety and depression in bariatric surgery patients: a prospective, follow-up study using structured clinical interviews | Q44996154 | ||
| Early and late abdominal bleeding after Roux-en-Y gastric bypass: sources and tailored therapeutic strategies. | Q45932292 | ||
| Genes and networks expressed in perioperative omental adipose tissue are correlated with weight loss from Roux-en-Y gastric bypass | Q46061889 | ||
| Incidence and outcome of anastomotic stricture after laparoscopic gastric bypass | Q46096473 | ||
| O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease | Q46214797 | ||
| Sperm parameters and male fertility after bariatric surgery: three case series | Q46229664 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bariatric surgery | Q357503 |
| precision medicine | Q17075943 | ||
| P304 | page(s) | 8 | |
| P577 | publication date | 2013-01-10 | |
| P1433 | published in | BMC Medicine | Q4835947 |
| P1476 | title | Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes | |
| P478 | volume | 11 |
| Q57175196 | "I didn't have to prove to anybody that I was a good candidate": a case study framing international bariatric tourism by Canadians as circumvention tourism |
| Q57788761 | 'The only chance of a normal weight life': A qualitative analysis of online forum discussions about bariatric surgery |
| Q28818847 | A Magnetic Soft Endoscopic Capsule-Inflated Intragastric Balloon for Weight Management |
| Q47406610 | Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss |
| Q49893206 | An overview of complications affecting the Central Nervous System following bariatric surgery |
| Q55280748 | Application of Metabolomics to Study Effects of Bariatric Surgery. |
| Q38410200 | Bariatric and metabolic surgery: a shift in eligibility and success criteria |
| Q41150177 | Bariatric surgery for women of reproductive age. |
| Q47193122 | Beyond weight loss: evaluating the multiple benefits of bariatric surgery after Roux-en-Y gastric bypass and adjustable gastric band. |
| Q36288858 | Comparing Medical Costs and Use After Laparoscopic Adjustable Gastric Banding and Roux-en-Y Gastric Bypass. |
| Q33552376 | Comparison of the efficacy of standard bariatric surgical procedures on Saudi population using the bariatric analysis and reporting outcome system |
| Q38366207 | Controversies in perioperative anesthetic management of the morbidly obese: I am a surgeon, why should I care? |
| Q35905537 | Development and Testing of a Magnetically Actuated Capsule Endoscopy for Obesity Treatment |
| Q42700900 | Drug disposition before and after gastric bypass: fenofibrate and posaconazole. |
| Q47769573 | Early major complications after bariatric surgery in the USA, 2003-2014: a systematic review and meta-analysis |
| Q38269818 | Ethical issues in the psychosocial assessment of bariatric surgery candidates |
| Q33164143 | Insulin-like growth factor 1 predicts post-load hypoglycemia following bariatric surgery: a prospective cohort study |
| Q28085070 | Interventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutions |
| Q47438831 | Mandatory weight loss during the wait for bariatric surgery |
| Q38821433 | Mental illness in bariatric surgery: A cohort study from the PORTAL network |
| Q39180620 | Nutritional Recommendations for Adult Bariatric Surgery Patients: Clinical Practice |
| Q36165782 | Older adults fighting obesity with bariatric surgery: Benefits, side effects, and outcomes |
| Q39405401 | Poor Health Behaviors Prior to Laparoscopic Sleeve Gastrectomy Surgery. |
| Q38981378 | Postoperative day one neutrophil-to-lymphocyte ratio as a predictor of 30-day outcomes in bariatric surgery patients. |
| Q35883320 | Preoperative factors and 3-year weight change in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium. |
| Q55265375 | Profilaxia da trombose venosa profunda em cirurgia bariátrica: estudo comparativo com doses diferentes de heparina de baixo peso molecular. |
| Q36550776 | Psychological assessment for bariatric surgery: current practices. |
| Q92082794 | Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database |
| Q45825981 | Robotic revisional bariatric surgery: single-surgeon case series |
| Q38658840 | Shifts in Food Preferences After Bariatric Surgery: Observational Reports and Proposed Mechanisms |
| Q47175320 | Surgical Training and Standardised Management Guidelines Improved the 30-Day Complication Rate After Abdominoplasty for Massive Weight Loss |
| Q38912802 | The Influence of the Orbera Intragastric Balloon Filling Volumes on Weight Loss, Tolerability, and Adverse Events: a Systematic Review and Meta-Analysis |
| Q33469719 | What's Age Got to Do With It? A Comparison of Bariatric Surgical Outcomes Among Young, Midlife, Older and Oldest Adults |
Search more.